NCT07814443

Brief Summary

This randomized controlled trial aims to evaluate the effect of combined traditional and paraspinal acupressure on restless legs syndrome and pruritus among patients undergoing hemodialysis. Participants will be randomly assigned to either an intervention group receiving the acupressure intervention in addition to routine hemodialysis care or a control group receiving routine care only. The severity of restless legs syndrome and pruritus will be assessed at predetermined time points using validated assessment tools. The study aims to determine whether the combined acupressure intervention is effective in reducing restless legs syndrome and pruritus symptoms in patients undergoing hemodialysis

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Sep 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress16%
Sep 2026Apr 2027

Study Start

First participant enrolled

September 1, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

September 5, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 11, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2027

Expected
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

September 11, 2026

Status Verified

September 1, 2026

Enrollment Period

7 months

First QC Date

September 5, 2026

Last Update Submit

September 5, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Restless Legs Syndrome Severity Assessed by the International Restless Legs Syndrome Study Group Rating Scale (IRLS)

    The questionnaire consisted of 10 items, each of which had a scale ranging from 0 (no impact) to 4 (very severe impact). RLS severity was defined as mild (0-10 points), moderate (11-20 points), severe (21-30 points), or very severe (31-40 points).

    Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention

  • Change in Pruritus Severity Assessed by the 5-D Itch Scale

    Pruritus severity will be assessed using the 5-D Itch Scale, which evaluates five dimensions of itching: duration, degree, direction, disability, and distribution. The total score ranges from 5 to 25, with higher scores indicating greater severity and impact of pruritus

    Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention

Study Arms (2)

intervention group (Vibration assisted acupressure)

EXPERIMENTAL

Participants in this group will receive vibration-assisted acupressure using an acupressure device applied to selected acupoints in addition to routine hemodialysis care. The intervention will be administered according to the study protocol to evaluate its effects on restless legs syndrome and pruritus among patients undergoing

Other: Vibration Assisted Acupressure

CONTROL GROUP

NO INTERVENTION

Participants will receive routine hemodialysis care without the acupressure intervention

Interventions

Vibration-assisted acupressure will be applied to selected traditional and paraspinal acupoints using a handheld vibration device. The intervention is designed to reduce the severity of restless legs syndrome and pruritus in patients undergoing hemodialysis. It will be administered according to a predefined intervention protocol in addition to routine hemodialysis care

intervention group (Vibration assisted acupressure)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients more than 18 years old on hemodialysis treatment for more than 2 sessions per week.
  • The patients on hemodialysis for more than 3 months
  • The patients who complain of restless leg syndrome and pruritus.
  • RLS diagnosis meeting the diagnostic criteria defined by the International Restless Legs Syndrome Study Group (IRLSSG).
  • At least moderate RLS symptoms (IRLS - total score ≥ 11)
  • Patients who score more than five on the 5D Pruritus scale.
  • Patient with a history of pruritus for more than 3 months.

You may not qualify if:

  • Patients with impaired skin integrity.
  • Patients with skin lesions in areas involved in acupressure therapy.
  • Patients with neurological deficits as perception of pain, may differ from other patients.
  • Patients with a body mass index (BMI) of more than \> 30 kg/m².
  • Patients with malignancy.
  • Patients with Jaundice.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Hussien Hemodialysis center

Dhi-Qar, Dhi Qar, 64001, Iraq

Location

MeSH Terms

Conditions

Restless Legs Syndrome

Condition Hierarchy (Ancestors)

Nervous System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersParasomniasMental Disorders

Study Officials

  • Hakima Shaker Hassan, Assist prof

    College of Nursing/ University of Baghdad

    STUDY DIRECTOR

Central Study Contacts

Alaa Kadhim Abdul-Hameed, Assist lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PHD student

Study Record Dates

First Submitted

September 5, 2026

First Posted

September 11, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

September 11, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations